| Dr Gail Carol Corrado, MD | |
|
467 Creamery Way, Exton, PA 19341-2508 | |
| (610) 363-1488 | |
| Not Available |
| Full Name | Dr Gail Carol Corrado |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 44 Years |
| Location | 467 Creamery Way, Exton, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780899187 | NPI | - | NPPES |
| 001436387 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084A0401X | Psychiatry & Neurology - Addiction Medicine | MD025384E (Pennsylvania) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD025384E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Creative Health Services, Inc | 2365340528 | 14 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter ended September 30, 2009.
Resverlogix Corp. today announced that it has entered into a Framework Agreement which sets forth the principal business terms for an equity investment and a license of RVX-208, for all indications, to Shenzhen Hepalink Pharmaceutical Co., Ltd. for China, Hong Kong, Taiwan and Macau (the "Territories").
Valeant Pharmaceuticals International, Inc. announced today that Valeant has signed an agreement to acquire Natur Produkt International, JSC, a specialty pharmaceutical company in Russia.
A new study from the research group of Dr. John Lewis at the University of Alberta (Edmonton, AB) and the Lawson Health Research Institute (London, ON) has confirmed that "invadopodia" play a key role in the spread of cancer. The study, published in Cell Reports, shows preventing these tentacle-like structures from forming can stop the spread of cancer entirely.
Although progress has been made in recent years, the matter of youth suicide in Quebec still needs to be more effectively addressed.
› Verified 9 days ago
| Entity Name | Creative Health Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124194121 PECOS PAC ID: 2365340528 Enrollment ID: O20040109000892 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter ended September 30, 2009.
Resverlogix Corp. today announced that it has entered into a Framework Agreement which sets forth the principal business terms for an equity investment and a license of RVX-208, for all indications, to Shenzhen Hepalink Pharmaceutical Co., Ltd. for China, Hong Kong, Taiwan and Macau (the "Territories").
Valeant Pharmaceuticals International, Inc. announced today that Valeant has signed an agreement to acquire Natur Produkt International, JSC, a specialty pharmaceutical company in Russia.
A new study from the research group of Dr. John Lewis at the University of Alberta (Edmonton, AB) and the Lawson Health Research Institute (London, ON) has confirmed that "invadopodia" play a key role in the spread of cancer. The study, published in Cell Reports, shows preventing these tentacle-like structures from forming can stop the spread of cancer entirely.
Although progress has been made in recent years, the matter of youth suicide in Quebec still needs to be more effectively addressed.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gail Carol Corrado, MD 2656 Primrose Ct, Chester Springs, PA 19425-3897 Ph: (610) 405-4015 | Dr Gail Carol Corrado, MD 467 Creamery Way, Exton, PA 19341-2508 Ph: (610) 363-1488 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter ended September 30, 2009.
Resverlogix Corp. today announced that it has entered into a Framework Agreement which sets forth the principal business terms for an equity investment and a license of RVX-208, for all indications, to Shenzhen Hepalink Pharmaceutical Co., Ltd. for China, Hong Kong, Taiwan and Macau (the "Territories").
Valeant Pharmaceuticals International, Inc. announced today that Valeant has signed an agreement to acquire Natur Produkt International, JSC, a specialty pharmaceutical company in Russia.
A new study from the research group of Dr. John Lewis at the University of Alberta (Edmonton, AB) and the Lawson Health Research Institute (London, ON) has confirmed that "invadopodia" play a key role in the spread of cancer. The study, published in Cell Reports, shows preventing these tentacle-like structures from forming can stop the spread of cancer entirely.
Although progress has been made in recent years, the matter of youth suicide in Quebec still needs to be more effectively addressed.
› Verified 9 days ago
Dr. Eduardo Meza, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 835 Springdale Dr, Exton, PA 19341 Phone: 610-363-1488 Fax: 484-713-1030 | |
Sachidanand D Kamtam, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 134 John Robert Thomas Dr, Exton, PA 19341 Phone: 484-252-4601 Fax: 610-873-2235 | |
Dr. Asim Rana, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 103 John Robert Thomas Dr, Exton, PA 19341 Phone: 484-879-6173 Fax: 484-879-6176 | |
Dr. Habibah E Mosley, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 103 John Robert Thomas Dr, Exton, PA 19341 Phone: 484-879-6173 |